BiPER Therapeutics
PrivateLast Round
SAFE
Dec 2, 2025
Total Funding Raised
$3.35M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BiPER Therapeutics is a biotechnology company that develops first-in-class small molecule therapeutics targeting BiP to treat cancer and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BiPER Therapeutics Comparables
Compare BiPER Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EtiraRx | 78% | |
| HiberCell | 77% | |
| SPIMA Therapeutics | 74% | |
BiPER Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| SAFE | Dec 2, 2025 | ||||
| Convertible Debt | Dec 17, 2024 | ||||
| Seed | Feb 14, 2023 |
Key People
Founding team and executive leadership
BiPER Therapeutics Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Grew 36% QoQ, from 11 to 15 employees.
- Apr 23, 2026
Grew 40% QoQ, from 10 to 14 employees.
BiPER Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BiPER Therapeutics's valuation, stock price, and market status.